Viral colitis is an important cause of refractory diarrhoea affecting the immunocompromised host. It has been noted in transplant recipients', and in patients suffering from lymphoma, leukaemia, AIDS and disseminated malignancy2'3. The case we report appears to be the first associated with advanced prostatic carcinoma.
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Case report A 65-year-old man was admitted with a 24 h episode of acute paraplegia. He gave a 2 months' history of general malaise, low back pain, and increasing symptoms of urinary outflow obstruction. Neurological Rment confirmed signs of spinal cord compression, and on rectal examination a T3 carcinoma of the prostate was found. Myelography showed a complete extradural block at IA and a bone scan revealed multiple metastases. Serum acid and alkaline phosphatases were both markedly raised. The cord compression was managed by dexamethasone, laminectomy, vertebral body biopsy (which showed metastatic adenocarcinoma with positive prostatic markers) and radiotherapy, supplemented by intravenous Honvan and then oral stilboestrol to control his carcinoma. With this combined approach his pain was controlled but he remained non-ambulant.
One month later he developed abdominal pain, diarrhoea and rectal bleeding, in the absence of any past history of inflammatory bowel disease. At colonoscopy, marked inflammation and ulceration ofthe sigmoid colon and rectum were noted, and the patient was given oral Salazopyrine. Stool microscopy and culture did not reveal any enteric pathogens and was Clostridium difficile toxin negative. Biopsy showed mucosal inflammation with intranuclear inclusion bodies ( Figure 1 ). Cytomegalovirus (CMV) and herpes simplex virus (HSV) complement fixation titres were both 1/320. Antibodies to human immunodeficiency virus (HIV) were not detected. Once a diagnosis of viral colitis was established, the Salazopyrine was stopped and intravenous acyclovir was given. This was associated with rapid clinical improvement, and repeat colonoscopy and biopsy showed resolution of the inflammatory changes. Three months later his carcinoma remains under symptomatic control and he has had no further episodes of colitis. disease is not always clear, evidence is increasing that CMV is fiequently responsible for colitis found in AIDS and renal transplant patients1 Furthermore, CMV infection may be the secondary event that precipitates toxic megacolon in patients with idiopathic ulcerative colitis4. Herpes simplex infection of the lower gastrointesinal tract in non-homosexual immunocompromised patients is less frequently reported and it can occur in the absence of mucocutaneous manifestations2.
Acyclovir has proven efficacy in HSV infections but is rarely active against CMV. Experience with dihydroxypropoxymethyl guanine in the treatment of CMV colitis in AIDS patients is promising and currently appears to be the drug of choice6.
This case appears to be the first ofviral colitis complicating metastatic carcinoma of the prostate, and probably was triggered by the combined immunosuppressive effects of the cancer and its treatment. It highlights the need to consider a viral aetiology when colitis in a cancer patient fails to respond to conventional therapy. In such instances prompt antiviral therapy may improve the prognosis.
